Clinical Trial Update: SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

View source ↗

Summary

The SIBYL study investigates therapy response assessment using liquid biopsy in cancer patients. The trial is currently recruiting and includes indications such…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Guardant Health, Inc. | Conditions: Non-small Cell Lung Cancer, Colorectal Cancer | Status: RECRUITING